Group 1: Market Potential and Business Strategy - The brain-machine interface market is expected to grow significantly due to technological advancements, aging population, and policy support, with a focus on sustainable development [2] - The company acknowledges uncertainties regarding future revenue contributions from the brain-machine business and advises investors to consider associated risks [2] - The company aims to deepen the integration of AI and BioCV core technologies to drive product innovation and implement a multi-brand strategy [3] Group 2: Financial Performance - The company's non-GAAP net profit growth rate has significantly outpaced revenue growth, primarily due to increased export ratios leading to higher gross margins and reduced sales expenses [3] - 76% of the company's revenue comes from overseas markets, with notable growth in the Americas, Asia-Pacific, Middle East, and Europe [3] Group 3: Technological Capabilities - The company has developed core technologies in brainwave detection, eye movement analysis, multimodal small model analysis, audio analysis, and facial micro-expression analysis for human-computer interaction [3] - The company is progressing with the development of a brain-machine interface product, focusing on emotion analysis, with a prototype expected by March 2026 [3] Group 4: Acquisition and Expansion Plans - The company is advancing its acquisition of Longzhiyuan and will provide updates through official announcements [3] - The construction of the manufacturing facility in Atlanta, USA, is currently underway [3]